70 / 74
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 2, March/April 2019
e6
AFRICA
6.
Brun-buisson C. Epidémiologie des états de choc septique grave.
La
Presse Médicale
2006;
35
: 513–520.
7.
Dellinger RP, Levy MM, Rhodes A,
et al
. Surviving Sepsis Campaign:
international guidelines for management of severe sepsis and septic
shock: 2012.
Intensive Care Med
2013;
39
(2): 165–228.
8.
Jaime J, Simon Grahe, Gourang P Patel, Ellen Elpern,
et al
. The safety
of dopamine versus norepinephrine as vasopressor therapy in septic
shock.
Chest
2005;
128
: 219S.
9.
Gueugniaud PY, Macabeo C, Ruiz J,
et al
. Catécholamines dans les états
de choc.
Médecine d’urgence
2001 : 49–60, SFAR 2001.
10. Sleeper LA, Reynolds HR, White HD,
et al
. A severity scoring system
for risk assessment of patients with cardiogenic shock: A report from the
SHOCK Trial and Registry.
Am Heart J
2010;
160
: 443–450.
11. Hochman JS, Sleeper LA, White HD,
et al
. One year survival following
early revascularization for cardiogenic shock.
J Am Med Assoc
2001;
285
(2): 190–192.
12. Hollenberg SM, Kavinsky CJ, Parrillo JE.
Cardiogenic shock.
Ann
Intern Med
1999;
131
(1): 47–59.